4.4 Article

COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays

期刊

ANNALS OF LABORATORY MEDICINE
卷 40, 期 6, 页码 439-447

出版社

KOREAN SOC LABORATORY MEDICINE
DOI: 10.3343/alm.2020.40.6.439

关键词

Coronavirus disease 2019; Laboratory diagnosis; Real-time RT-PCR; Guidelines; Korea

资金

  1. KCDC [4837-301]
  2. Bio AMP
  3. Medical Technology Development Program of the National Research Foundation (NRT) of Korea - Korea government [NRF-2016M3A9B6918716]
  4. National Research Foundation of Korea [2016M3A9B6918716] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection. Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide. Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention. However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions. Therefore, this guideline is intended as a practical and technical supplement to the Guidelines for Laboratory Diagnosis of COVID-19 in Korea.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据